In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 28th, 2008 | 30 | Yes |
Popular Name: Fluphenazine hydrochloride Fluphenazine hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 146-56-5 , 69-23-8 , 78126-11-1 , [146-56-5] , [69-23-8]
146-56-5; Fluphenazine dihydrochloride; Prestwick_225
2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol
2-(4-(3-(2-(Trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl decanoate
2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol dihydrochloride
2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethyl decanoate
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl decanoate
2-{4-[3-(2-Trifluoromethyl-phenothiazin-10-yl)-propyl]-piperazin-1-yl}-ethanol
69-23-8; D07977; Fluphenazine (INN); Moditen (TN)
78126-11-1; D02163; Flumezin (TN); Fluphenazine maleate (JAN)
CPD000058411; Fluphenazine dihydrochloride; SAM001246863
CPD000058411; FLUPHENAZINE HYDROCHLORIDE; SAM001246863
Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
Decanoic acid, 2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazinyl)ethyl ester
Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
Decanoic acid, 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester
Fluorfenazine;Fluorophenazine;Fluorphenazine;Fluphenazine Decanoate;Triflumethazine
Fluphenazine (dihydrochloride)
Fluphenazine decanoate (JAN/USP)
Fluphenazine dihydrochloride, 98%
INN); Fluphenazine Hydrochloride (BAN
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 4.51 | 8.77 | -46.48 | 2 | 4 | 1 | 33 | 438.539 | 7 | ↓ |
Mid Mid (pH 6-8) | 4.51 | 6.53 | -7.87 | 1 | 4 | 0 | 32 | 437.531 | 7 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 1.90e-02 g/l | DrugBank-approved |
therap | antipsychotic, H1 antihistamine | MicroSource US Drugs |
mechanism | brain-stem | IBScreen Bioactives |
mechanism | Calmodulin-antagonist | IBScreen Bioactives IBScreen Bioactives |
Therapy | Dopamine receptor antagonist; antipsychotic | SMDC Iconix |
mechanism | Dopamine-antagonist | IBScreen Bioactives |
mechanism | Dopamine-release inhibitor | IBScreen Bioactives |
mechanism | Dopamine-turnover stimulant in the forebrain | IBScreen Bioactives |
therap | H1 antihistamine | MicroSource Spectrum |
mechanism | hypothalamus | IBScreen Bioactives |
mechanism | Increases neuronal firing-rate in the midbrain | IBScreen Bioactives |
mechanism | limbic-system | IBScreen Bioactives |
mechanism | Mechanism of action not fully understood. | IBScreen Bioactives |
mechanism | medulla | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : Sigma Chemical Company; NCC_SUPPLIER_STRUCTURE_ID : F4765; 2 hydrogen chloride | NIH Clinical Collection via PubChem |
biological_use | Neuroleptic | IBScreen Bioactives |
UniProt Database Links | ODB2_ARATH | ChEBI |
mechanism | Postsynaptic dopamine-antagonist in: basal ganglia | IBScreen Bioactives |
biological_use | Psychosedative | IBScreen Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: Sigma Chemical Company; SUPPLIER_STRUCTURE_ID: F4765; SALT: 2 hydrogen chloride | NIH Clinical Collection via PubChem |
biological_use | Tranquilliser | IBScreen Bioactives IBScreen Bioactives |
Purity | USP25 | APIChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
5HT6R-1-E | Serotonin 6 (5-HT6) Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 50 | 0.34 | Binding ≤ 10μM |
ADCY2-2-E | Adenylate Cyclase Type II (cluster #2 Of 2), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
ADCY3-2-E | Adenylate Cyclase Type III (cluster #2 Of 2), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
ADCY4-2-E | Adenylate Cyclase Type IV (cluster #2 Of 2), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
ADCY5-2-E | Adenylate Cyclase Type V (cluster #2 Of 2), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
ADCY6-2-E | Adenylate Cyclase Type VI (cluster #2 Of 2), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
ADCY8-1-E | Adenylate Cyclase Type VIII (cluster #1 Of 2), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
ANDR-1-E | Androgen Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 800 | 0.28 | Binding ≤ 10μM |
D4A3N4-1-E | Brain Adenylate Cyclase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
DRD1-1-E | Dopamine D1 Receptor (cluster #1 Of 4), Eukaryotic | Eukaryotes | 179 | 0.31 | Binding ≤ 10μM |
DRD3-1-E | Dopamine D3 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3 | 0.40 | Binding ≤ 10μM |
DRD5-1-E | Dopamine D5 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 21 | 0.36 | Binding ≤ 10μM |
HRH1-1-E | Histamine H1 Receptor (cluster #1 Of 2), Eukaryotic | Eukaryotes | 40 | 0.35 | Binding ≤ 10μM |
Q8CFM9-1-E | Adenylate Cyclase Type VII (cluster #1 Of 1), Eukaryotic | Eukaryotes | 80 | 0.33 | Binding ≤ 10μM |
SCN1A-1-E | Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.25 | Binding ≤ 10μM |
SCN2A-1-E | Sodium Channel Protein Type II Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.25 | Binding ≤ 10μM |
SCN3A-1-E | Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.25 | Binding ≤ 10μM |
SCN8A-1-E | Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3700 | 0.25 | Binding ≤ 10μM |
DRD2-14-E | Dopamine D2 Receptor (cluster #14 Of 24), Eukaryotic | Eukaryotes | 1 | 0.42 | Binding ≤ 10μM |
PDR5-1-F | Pleiotropic ABC Efflux Transporter Of Multiple Drugs (cluster #1 Of 1), Fungal | Fungi | 1700 | 0.27 | Binding ≤ 10μM |
Z50425-3-O | Plasmodium Falciparum (cluster #3 Of 22), Other | Other | 3162 | 0.26 | Functional ≤ 10μM |
Z50466-4-O | Trypanosoma Cruzi (cluster #4 Of 8), Other | Other | 4000 | 0.25 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 80 | 0.33 | Binding ≤ 1μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 80 | 0.33 | Binding ≤ 1μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 80 | 0.33 | Binding ≤ 1μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 80 | 0.33 | Binding ≤ 1μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 80 | 0.33 | Binding ≤ 1μM |
Q8CFM9_RAT | Q8CFM9 | Adenylate Cyclase Type VII, Rat | 80 | 0.33 | Binding ≤ 1μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 80 | 0.33 | Binding ≤ 1μM |
ANDR_RAT | P15207 | Androgen Receptor, Rat | 800 | 0.28 | Binding ≤ 1μM |
D4A3N4_RAT | D4A3N4 | Brain Adenylate Cyclase 1, Rat | 80 | 0.33 | Binding ≤ 1μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 179 | 0.31 | Binding ≤ 1μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 1.44 | 0.41 | Binding ≤ 1μM |
DRD3_HUMAN | P35462 | Dopamine D3 Receptor, Human | 3.21 | 0.40 | Binding ≤ 1μM |
DRD5_HUMAN | P21918 | Dopamine D5 Receptor, Human | 21 | 0.36 | Binding ≤ 1μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 40 | 0.35 | Binding ≤ 1μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 50 | 0.34 | Binding ≤ 1μM |
ADCY2_RAT | P26769 | Adenylate Cyclase Type II, Rat | 80 | 0.33 | Binding ≤ 10μM |
ADCY3_RAT | P21932 | Adenylate Cyclase Type III, Rat | 80 | 0.33 | Binding ≤ 10μM |
ADCY4_RAT | P26770 | Adenylate Cyclase Type IV, Rat | 80 | 0.33 | Binding ≤ 10μM |
ADCY5_RAT | Q04400 | Adenylate Cyclase Type V, Rat | 80 | 0.33 | Binding ≤ 10μM |
ADCY6_RAT | Q03343 | Adenylate Cyclase Type VI, Rat | 80 | 0.33 | Binding ≤ 10μM |
Q8CFM9_RAT | Q8CFM9 | Adenylate Cyclase Type VII, Rat | 80 | 0.33 | Binding ≤ 10μM |
ADCY8_RAT | P40146 | Adenylate Cyclase Type VIII, Rat | 80 | 0.33 | Binding ≤ 10μM |
ANDR_RAT | P15207 | Androgen Receptor, Rat | 800 | 0.28 | Binding ≤ 10μM |
D4A3N4_RAT | D4A3N4 | Brain Adenylate Cyclase 1, Rat | 80 | 0.33 | Binding ≤ 10μM |
DRD1_HUMAN | P21728 | Dopamine D1 Receptor, Human | 179 | 0.31 | Binding ≤ 10μM |
DRD2_HUMAN | P14416 | Dopamine D2 Receptor, Human | 1.44 | 0.41 | Binding ≤ 10μM |
DRD3_HUMAN | P35462 | Dopamine D3 Receptor, Human | 3.21 | 0.40 | Binding ≤ 10μM |
DRD5_HUMAN | P21918 | Dopamine D5 Receptor, Human | 21 | 0.36 | Binding ≤ 10μM |
HRH1_HUMAN | P35367 | Histamine H1 Receptor, Human | 40 | 0.35 | Binding ≤ 10μM |
PDR5_YEAST | P33302 | Pleiotropic ABC Efflux Transporter Of Multiple Drugs, Yeast | 1700 | 0.27 | Binding ≤ 10μM |
5HT6R_HUMAN | P50406 | Serotonin 6 (5-HT6) Receptor, Human | 50 | 0.34 | Binding ≤ 10μM |
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 3700 | 0.25 | Binding ≤ 10μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 3700 | 0.25 | Binding ≤ 10μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 3700 | 0.25 | Binding ≤ 10μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 3700 | 0.25 | Binding ≤ 10μM |
Z50425 | Z50425 | Plasmodium Falciparum | 1258.92541 | 0.28 | Functional ≤ 10μM |
Z50466 | Z50466 | Trypanosoma Cruzi | 4000 | 0.25 | Functional ≤ 10μM |
Description | Species |
---|---|
Adenylate cyclase activating pathway | |
Adenylate cyclase inhibitory pathway | |
CREB phosphorylation through the activation of Adenylate Cyclase | |
Dopamine receptors | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
G alpha (s) signalling events | |
G alpha (z) signalling events | |
Glucagon signaling in metabolic regulation | |
Histamine receptors | |
Interaction between L1 and Ankyrins | |
Nuclear Receptor transcription pathway | |
PKA activation | |
PKA activation in glucagon signalling | |
Serotonin receptors | |
Vasopressin regulates renal water homeostasis via Aquaporins |